# CBRE Group

Type: Company (CBRE)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/cbre-group
Canonical HTML page: https://gethealthbrief.com/entity/cbre-group

## Recent coverage (1 stories)

### Teva's $1.91-$2.11 EPS Guidance Misses Consensus, Testing Pharma Resilience
2026-08-05 14:16:51 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Teva Pharmaceutical's FY2026 EPS guidance fell short of the $2.17 consensus, while revenue projections of $16.5-$16.9B matched expectations. For healthcare leaders, the miss underscores ongoing generic drug pricing pressures and the importance of a diversified pipeline.
Full story: https://gethealthbrief.com/story/teva-fy2026-guidance-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.